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Foreword 
AMERICANS DESERVE VALUE from their healthcare experiences. Value—encompassing 
quality, cost, and outcomes and ideally driven by patient preferences of care—is sorely 
lacking in the U.S. healthcare system today. 
Per capita spending on healthcare in the United States is more than double that of other 
industrialized nations, yet the United States ranks poorly compared with other countries on 
key indicators of the quality of care patients receive and their health status. Furthermore, 
approximately 30 percent of healthcare spending is devoted to services that provide no 
health benefit to patients. These are the hallmarks of an inefficient system. 
Efficiency—so important that the Institute of Medicine has deemed it one of the six 
aims of a quality healthcare system—is notoriously difficult to measure. The road map to 
healthcare quality improvement must include measures of efficiency that not only accord 
with patients’ preferences but also reflect national priorities and goals for quality improve-
ment. Thus, the National Quality Forum (NQF), which was established in 1999 to facilitate 
widespread healthcare quality improvement, sought to endorse a workable and effective 
framework for evaluating the efficiency of care over time. 
This report represents the culmination of that project. The framework contained herein 
was vetted through NQF’s public comment and voting process, granting it NQF-endorsed® 
status. It is viewed as a living document that will continue to evolve as evidence and 
practice continue to inform its key components. 
NQF thanks the Evaluating Efficiency Across Patient-Focused Episodes of Care Steering 
Committee, the Committee’s co-chairs Elliott Fisher, MD, MPH, and Kevin Weiss, MD, 
MPH, and NQF Members for their stewardship of this project and their commitment to the 
creation of a high-performing, high-value healthcare system. 
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Executive Summary 
ALTHOUGH HEALTHCARE SPENDING per capita in the United States is more than 
double that of other industrialized nations, the United States ranks comparatively low on 
key indicators of the quality of care and population health status.1 Inefficiencies such as 
duplicate tests and widespread regional practice variations plague the system. In one study, 
more than 4 in 10 Americans reported experiencing inefficient, poorly coordinated, or 
unsafe care.2 This combination of high cost and low quality indicates a system that is of 
poor value, and Americans clearly deserve better. 
Performance measurement is essential to system transformation.3 Substantial progress has 
been made in developing and implementing reliable measures of healthcare quality. And 
although there are several notable exceptions, most quality measurement efforts are poorly 
coordinated and do not focus on areas with the greatest potential to improve outcomes or 
control costs. Thus, we have yet to achieve the healthcare system we desire that embraces 
the Institute of Medicine’s aims for safe, timely, effective, efficient, equitable, and patient-
centered care. 
To provide guidance to key stakeholder groups in accelerating toward a high-performing, 
high-value healthcare system, the National Quality Forum (NQF) convened a Steering 
Committee to develop a framework for evaluating the efficiency of care over time, including 
clear definitions and a shared vision of what can be achieved around quality, cost, and 
value, serving as a foundation for the work of larger performance improvement efforts. 
This report presents the NQF-endorsed® measurement framework for assessing efficiency, 
and ultimately value, associated with the care over the course of an episode of illness and 
sets forth a vision to guide ongoing and future efforts. 
This framework consists of the following:
 
❙ key terms and definitions;
 
❙ an explanation of the patient-focused episode of care approach;
 
❙ domains for performance measurement for evaluating efficiency; and
 
❙ guiding principles.
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Measurement Framework: 
Evaluating Efficiency 
Across Patient-Focused 
Episodes of Care 
Key Terms and Definitions4 
❙ Quality of care is a measure of performance 
on the Institute of Medicine’s (IOM) six 
aims for healthcare: safety, timeliness, 
effectiveness, efficiency, equity, and patient­
centeredness. 
❙ Cost of care is a measure of the total 
healthcare spending, including total 
resource use and unit price(s), by payor 
or consumer, for a healthcare service or 
group of healthcare services associated with 
a specified patient population, time period, 
and unit(s) of clinical accountability. 
❙ Efficiency of care is a measure of cost of 
care associated with a specified level of 
quality of care. “Efficiency of care” is a 
measure of the relationship of the cost of 
care associated with a specific level of 
performance measured with respect to the 
other five IOM aims of quality. 
❙ Value of care is a measure of a specified 
stakeholder’s (such as an individual 
patient’s, consumer organization’s, payor’s, 
provider’s, government’s, or society’s) 
preference-weighted assessment of a 
particular combination of quality and 
cost of care performance. 
Purpose of the Healthcare 
Delivery System 
The purpose of the healthcare delivery system 
is to improve health, reduce the burden of 
illness, and maximize the value of individual 
and societal resources allocated to healthcare 
and is fundamentally rooted in the needs of 
the patient, and, more broadly, society. An 
effective measurement framework should 
contribute to that purpose by supporting 
judgments about the degree to which the 
healthcare delivery system and its component 
parts contribute to achieving this purpose. 
Theoretical Construct: 
Episodes of Care Approach 
An episode of care is defined as “a series 
of temporally contiguous healthcare services 
related to the treatment of a given spell of 
illness or provided in response to a specific 
request by the patient or other relevant entity.”5 
The Committee developed a generic episode 
of care model, which can be used to track the 
core components—population at risk, evalua­
tion and initial management, and follow-up 
care—that must be measured and evaluated 
over the course of an episode of care. These 
components are foundational to any assess­
ment of efficiency. This model is adaptable to 
multiple types of episodes, and the construct 
is designed to be applied to a broad set of 
health conditions; this report has applied it 
to two different types of conditions—acute 
myocardial infarction and low back pain—to 
allow for examination of an acute condition 
and transition between providers and settings, 
as well as a chronic, preference-sensitive 
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Generic Episode of Care 
Population at Risk 
PHASE 1 
Clinical episode begins 
End of Episode 
• Risk-adjusted health outcomes 
(i.e., mortality & functional status) 
• Risk-adjusted total cost of care 
PHASE 2 
PHASE 3 
Evaluation & Initial 
Management Follow-up Care 
Appropriate Times Throughout Episode 
• Determination of key patient attributes for 
risk-adjustment 
• Assessment of informed patient preferences 
and the degree of alignment of care 
processes with these preferences 
• Assessment of symptom, functional, and 
emotional status 
Time 
condition in which shared decision making 
plays a significant role. Subsequent work has 
been completed on breast and colorectal 
cancers, diabetes, and substance use illness.6 
Domains for Performance 
Measurement 
The following domains represent the essential 
components and subcomponents for measuring 
efficiency as it relates to an episode of care. 
❙ Health outcomes important to patients 
• Health status/health-related quality of life 
• Patient experience with care 
❙ Cost and resource use 
❙ Processes of care 
Guiding Principles 
The following principles are intended to 
guide development and implementation of the 
measurement framework as applied across 
episodes of care. 
1. Efficiency measurement is multidimensional. 
2. The choice of measures to inform judgments 
on efficiency should include consideration 
of potential leverage. 
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3. Measures used to inform judgments on effi­
ciency should promote shared accountability 
across providers and should be assigned 
to the smallest unit of accountability as 
technically feasible. 
4. Measures used to inform judgments on 
efficiency should respond to the need to 
harmonize measurement across settings 
of care. 
5. Measures to inform judgments on efficiency 
should be used for benchmarking. 
6. Public reporting of measures of efficiency 
should be meaningful and understandable 
to consumers and entities accountable for 
their care. 
7. Inappropriate care cannot be efficient. 
8. The measurement framework should 
achieve its intended purpose and should be 
monitored for unintended consequences. 
9. Measures to inform judgments on efficiency 
should be an integral part of a continuous 
learning system. 
Notes 
1	 The Commonwealth Fund, Mirror, Mirror on the Wall: An 
International Update on the Comparative Performance of 
American Healthcare. New York: The Commonwealth Fund; 
2007. Available at www.commonwealthfund.org/ 
usr_doc/1027_Davis_mirror_mirror_international_up 
date_final.pdf. Last accessed January 2009, p. 1. 
2	 Ibid. 
3	 Institute of Medicine. Performance Measurement: 
Accelerating Improvement. Washington, DC: National 
Academies Press; 2006. 
4	 These terms are adopted from AQA Principles of Efficiency 
Measures. Available at www.aqaalliance.org/files/ 
PrinciplesofEfficiencyMeasurementApril 2006.doc. 
Last accessed January 2009. 
5	 Hornbrook MC, Hurtado AV, Johnson RE, Health care 
episodes: definition, measurement and use, Med Care Rev, 
1985;42(2):163-218, p. 171. 
6	 Additional information on subsequent work completed can be 
found at www.qualityforum.org/Projects/Episodes_ 
of_Care_Framework.aspx. 
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Introduction and Overview 
Statement of the Problem 
Most Americans will not be able to afford healthcare if expenditures for healthcare services 
continue to grow at their current pace. A recent survey of U.S. adults found that 50 percent 
of middle- and lower-income families reported serious problems paying for care, and an 
equal proportion are worried about the affordability of healthcare for themselves and their 
families in the near future.1 Although per capita spending on healthcare in the United States 
is more than double that of other industrialized nations, the United States ranks poorly com­
pared with other countries on key indicators of the quality of medical care and the health 
status of the population.2 For example, in a comparative study of the United States and five 
other industrialized nations, the United States ranked last in safe care and had the highest 
infant mortality rates.3 In light of these findings, it is not surprising that 42 percent of adults 
in this country report experiencing inefficient, poorly coordinated, or unsafe care over the 
past two years.4 
Inefficiency and waste are pervasive. Patients often receive duplicate tests or do not have 
their medical records available when they visit a doctor. More money is spent in the United 
States on administrative functions related to insurance than in other countries—7.3 percent 
of national expenditures on health. If the United States were in-line with other countries who 
have mixed private-public insurance systems, it is estimated that $32 to $46 billion a year 
could be saved.5 Clearly, Americans deserve better value for their healthcare dollars. 
Widespread variation in spending also occurs across the country. This variation often is 
unrelated (or, at times, is inversely related) to the quality of care. For example, Medicare 
beneficiaries in higher-spending regions of the United States do not experience higher 
quality of care than those in lower-spending regions. In some cases the quality of care is 
worse, as indicated by health outcomes and patient satisfaction. Differences in spending 
appear to be due to differences in physician practice patterns that are driven in part by the 
greater per-capita supply of hospitals and specialists: Patients in higher-spending regions 
are much more likely to be treated as inpatients and by multiple specialists compared with 
similar patients in lower-spending regions—and they receive more tests, imaging services, 
and minor procedures.6 
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However, there are reasons for optimism. 
Performance measurement is widely accepted 
as essential to improvement—by identifying 
opportunities for improvement, motivating 
providers to improve, and providing the basis 
for aligning incentives with better perform-
ance—and substantial progress has been made 
recently in the development and implementation 
of reliable measures. Promising examples exist 
across the country, in which organizations are 
improving the quality of care while shedding 
waste and controlling costs (see Appendix A). 
Finally, there is a growing recognition that the 
potential savings from reducing waste and 
improving efficiency are substantial—with 
an estimated 30 percent of U.S. healthcare 
spending devoted to services that provide no 
health benefit.7 
Still, although significant resources are 
being invested in the development of perform­
ance measures by many organizations, current 
efforts are poorly coordinated and often fail 
to focus on high-leverage areas that have 
the greatest potential to improve quality and 
control costs. These efforts are thus unlikely to 
lead to fundamental change in the healthcare 
delivery system.8 Notwithstanding certain 
exceptions, widespread adoption and diffusion 
of best practices have been slow to occur. 
Multiple stakeholders must align in order to 
accelerate improvement by: 
❙ creating a road map for healthcare 
quality improvement that includes 
priorities and performance improvement 
goals to unify and build upon existing 
efforts, and set a more deliberate course 
of action for the nation; 
❙ developing a workable and effective 
framework for evaluating the efficiency 
of care over time, including clear definitions 
of terms and a shared vision of what can 
be achieved around quality, cost, and value 
that promotes better care coordination and 
a sense of shared accountability among the 
multiple providers involved in a patient’s 
care; 
❙ developing performance measures and 
efficient data collection and reporting 
strategies that will inform our efforts to 
improve key areas such as enhancing care 
coordination, aligning care with patients’ 
preferences, and controlling the cost of care; 
and 
❙ creating an integrated national, 
regional, and local leadership model 
that will guide and enable efforts to drive 
care improvement. 
Strategic Direction 
To create a road map for healthcare 
quality improvement, the National Quality 
Forum (NQF) convened the National Priorities 
Partnership (NPP), a collaborative effort of 
32 major national organizations (Partners) that 
collectively influence every part of the health-
care system. The Partners have identified a set 
of National Priorities and Goals for national 
action that aggressively targets eliminating 
harm, eradicating disparities, reducing disease 
burden, and removing waste from the health-
care system.9 The Partners also have agreed to 
work collaboratively and with policymakers, 
healthcare leaders, and other stakeholders to 
develop action plans around the Priorities and 
to align the drivers of change (e.g., payment 
reform, performance measurement, and 
accreditation and certification) around 
common goals.10 
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To develop a workable and effective 
framework for evaluating the efficiency 
of care over time, NQF sought to develop 
a comprehensive measurement framework in 
order to evaluate efficiency, and ultimately 
value, across patient-focused episodes of 
care—that is, the care of people over the 
course of an episode of illness. As with other 
projects, NQF convened a multistakeholder 
Steering Committee (Appendix B) to shepherd 
this work. 
In an attempt to operationalize the measure­
ment framework, the Committee targeted two 
very different types of conditions—acute 
myocardial infarction and low back pain—to 
determine the applicability of the framework to 
these conditions, thus making the framework 
more likely to be generalizable. 
The formative work of this Committee and 
the ongoing work of NPP cumulatively hope to 
lead to the development of performance 
measures and efficient data collection 
and reporting strategies and to the encour­
agement of the creation of an integrated 
national, regional, and local leadership 
model that will guide and enable efforts to 
drive care improvement. These efforts will 
require ongoing engagement of the many 
stakeholder groups that already have advanced 
performance measurement. Ultimately, these 
efforts will facilitate better alignment of meas­
urement development and reporting activities 
with the National Priorities and Goals; address 
gaps in the quality measurement agenda; 
and begin to define longitudinal performance 
metrics of patient-level outcomes, resource use, 
and key processes of care. Furthermore, these 
efforts aim to simplify the measurement process 
so that it can motivate and support healthcare 
professionals, provider organizations, patients, 
and communities to ensure that patients receive 
the most efficient, high-quality healthcare 
possible. 
The framework contained in this document 
proposes a patient-centered approach to 
measurement that focuses on patient-level 
outcomes over time—soliciting feedback on 
patient and family experiences; assessing 
functional status and quality of life; ensuring 
treatment options are aligned with informed 
patient preferences; and using resources 
wisely. It will require fundamental change in 
the healthcare delivery system. 
The framework presented here is viewed as 
a living document that will continue to evolve 
as we learn more about how to best address 
individuals with complex chronic illnesses and 
better integrate public health and personal 
health systems. Nonetheless, this framework 
provides a starting point for identifying 
measurement gaps and for examining models 
of shared accountability to help move us closer 
toward attaining a high-performing, high-value 
healthcare system. 
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Focus of this Report 
IN THIS REPORT, the groundwork is laid for a measurement framework that evaluates 
efficiency, and ultimately value, across patient-focused episodes of care. This framework 
will help key stakeholders move toward a high-performing healthcare system that is patient-
centered, focused on quality, mindful of costs, and vigilant against waste. 
Measurement Framework 
The Committee’s recommended measurement framework is presented below. First, key terms 
are defined to establish a common understanding of what is meant by “efficiency” and 
related constructs (such as quality and cost). Next, the purpose of the healthcare delivery 
system and the role that performance measurement should play in achieving that purpose 
are clarified. The definitions and the purpose provide the foundation for the Committee’s 
decision to emphasize the importance of focusing on health outcomes and total costs over 
episodes of care when measuring performance. The advantages and disadvantages of the 
episode of care approach to performance measurement are provided, and a model of a 
generic episode of care is explained. Finally, the recommended domains for performance 
measurement and a set of principles to guide future work are presented. 
Key Terms and Definitions 
The Committee recognized the importance of agreeing upon a common vocabulary around 
efficiency measurement, and it capitalized on the many efforts already underway in the 
field. The Committee looked to the work of the AQA, which had already come to consensus 
on straightforward definitions for the constructs that are inherent to measuring and evaluating 
efficiency, and which gained approval from the AQA membership.11 The Committee agreed 
with AQA’s approach, and it recommended the adoption of the definitions in Box 1 as a 
means to promote a common understanding among the many stakeholders committed to 
this work and to better align existing and future undertakings in this area. Appendix C 
discusses these terms in greater detail and provides a “real-life” example of how they can 
be applied. 
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Box 1—Key Terms and Definitions
 
The four terms and accompanying definitions presented below are distinct but interrelated con­
structs. The Committee recommended that measurement within these constructs not be pursued 
individually or in isolation, but rather as an essential subcomponent of a larger set of measures 
needed to adequately assess efficiency overall. 
❙ Quality of care is a measure of performance on the six Institute of Medicine (IOM) specified 
healthcare aims: safety, timeliness, effectiveness, efficiency, equity, and patient-centeredness. 
❙ Cost of care is a measure of the total healthcare spending, including total resource use 
and unit price(s), by payor or consumer, for a healthcare service or group of healthcare 
services, associated with a specified patient population, time period, and unit(s) of clinical 
accountability. 
❙ Efficiency of care is a measure of cost of care associated with a specified level of quality of 
care. “Efficiency of care” is a measure of the relationship of the cost of care associated with 
a specific level of performance measured with respect to the other five IOM aims of quality. 
❙ Value of care is a measure of a specified stakeholder’s (such as an individual patient’s, 
consumer organization’s, payor’s, provider’s, government’s, or society’s) preference-weighted 
assessment of a particular combination of quality and cost of care performance. 
Purpose of the Healthcare Delivery 
System and Supporting Role of the 
Performance Measurement System 
Ultimately, a measurement framework will 
be deemed successful to the degree that it 
contributes to the success of the healthcare 
delivery system at achieving its purpose. 
Drawing on earlier work by the Institute of 
Medicine (IOM)12 and others, the Committee 
concluded that the purpose of the healthcare 
delivery system is rooted fundamentally in 
the needs of the patient, and more broadly, 
society. The purpose of the healthcare 
delivery system is 
to improve health, reduce the burden 
of illness, and maximize the value of 
individual and societal resources allocated 
to healthcare. 
Accordingly, the measurement framework 
should support judgments about the degree to 
which the healthcare delivery system and its 
component parts (e.g., providers, health plans, 
payers, and government agencies) contribute 
to achieving this purpose. Even more impor­
tantly, a performance measurement system 
should both motivate and support continual 
improvement in the healthcare delivery system 
and its demonstrated capacity to achieve the 
goal of improving health and reducing both 
the cost and burden of illness. 
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The Committee recognized that having a 
clear purpose will not eliminate disagreements 
or the need to make difficult decisions. Different 
stakeholders will have different perspectives on 
efficiency. For example, a patient may consider 
being seen for an appointment in a timely 
manner as a relevant barometer of efficiency, 
considering the opportunity costs of running 
late (e.g., missed wages), whereas a provider 
may consider it more efficient to overbook 
patients to ensure that all appointments are 
filled and the practice sustained. However, the 
Committee concluded that its work should pro­
ceed primarily from the patient’s perspective, 
which offers a clear path toward redesigning 
payment and care models to reduce the burden 
of illness, while eliminating waste and maxi­
mizing value. A more difficult set of issues 
involves decisions about how to best allocate 
resources to the healthcare system itself 
(compared to other societal investments) and 
among the potential competing priorities within 
healthcare. In this case as well, however, 
judgments and prioritization will be fairer 
and better aligned with the purpose of the 
healthcare system to the extent that they can 
be based on reliable information about the 
impact of different clinical interventions and 
approaches to care delivery on patients’ and 
populations’ health, the burden of illness, and 
the overall costs and value to patients of the 
alternative approaches to providing care.13 
Episodes of Care 
Rationale for using episodes of care 
to characterize performance 
A measurement framework that can inform 
stakeholders’ judgments of the degree to which 
the delivery system is improving health and 
reducing the burden of illness, at an appropri­
ate level of investment, should parallel the 
natural trajectory of the clinical conditions 
(i.e., injuries, diseases, and disabilities) to be 
assessed.14 Therefore, the Committee found the 
theoretical construct of an episode of care as a 
useful approach to characterizing performance. 
Specifically, an episode of care is defined as 
a series of temporally contiguous healthcare 
services related to the treatment of a given 
spell of illness or provided in response to 
a specific request by the patient or other 
relevant entity (p. 171).15 
The Committee concluded that an episode 
perspective is required to determine if the 
delivery system is indeed achieving its intended 
purpose, because this approach allows for 
care to be analyzed over time and offers a 
better assessment of the patient’s resultant 
health status. 
Types of Episodes of Care 
An episode of care may be acute, such as a 
fractured arm (for which onset is easily defined 
and the period of recovery is relatively pre­
dictable), or more chronic, such as diabetes 
(for which onset is gradual, treatment requires 
ongoing efforts, and the goals are to prevent 
disease progression and to minimize complica­
tions over a prolonged period of time). A single 
episode may also include both acute and 
chronic care. In the case of heart attacks, 
for example, the initial management requires 
effective coordination of acute care resources 
(e.g., emergency services, hospital emergency 
rooms, multiple healthcare professionals, 
cardiac catheterization suites, and intensive 
care units). However, maximal recovery 
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requires marshalling post-acute care services 
(e.g., rehabilitation) and implementing effective, 
secondary strategies (e.g., smoking cessation 
counseling, lipid-lowering medications) to 
prevent further progression of disease and 
perhaps another heart attack. These examples 
underscore the need to pay careful attention to 
the varying durations of different healthcare 
episodes and to the important contributions 
of multiple healthcare professionals (e.g., 
nurses, pharmacists, allied health professionals, 
physicians, and others) to the delivery of 
high-quality care. 
Advantages of an Episode of Care Approach 
The Committee identified several advantages 
to using the episode of care approach to 
assess performance. First and foremost, this 
approach offers a more patient-centered way 
to evaluate health system performance, and it 
may, therefore, help to address many of the 
gaps in our current performance measurement 
system that were identified by the IOM16 and 
others. Because the natural trajectory of many 
episodes extends over a long time period 
(e.g., one year), evaluation can provide insight 
into how effectively services are coordinated 
across multiple settings and during critical 
transition points, such as discharge from the 
hospital to the nursing home, where the evi­
dence shows that errors and miscommunications 
are likely to occur.17,18 A longitudinal, episode-
based approach contrasts sharply with current 
approaches to performance assessment, which 
usually focus on a specific setting or provider 
(e.g., hospital or nursing home) and on a single 
point in time. A longitudinal approach to 
measurement can help to shift the focus away 
from how individual providers act to how 
multiple providers can more effectively work 
together to improve the quality, cost, and 
outcomes of care. The IOM called for 
measurement approaches that foster shared 
accountability—where all members of the 
team are held accountable for high-quality 
care and for the “warranty” many are calling 
on the delivery system to provide to patients.19 
Second, the Committee considered the 
episode of care approach to be a way to shift 
performance measurement toward assessments 
that allow judgments to be made about value— 
by providing measures of quality, cost of care, 
and outcomes that can only be interpreted in 
light of concordance with patients’ well-informed 
preferences. While they may serve as indicators 
of over-utilization if appropriately benchmarked, 
traditional measures of resource use that focus 
on the volume of services received by a defined 
population (e.g., practitioner office visits, 
hospital admissions, and surgical procedures) 
provide an incomplete picture of how medical 
services relate to one another, and they provide 
no insight into the relationship between the 
delivery of service(s) and the outcome achieved 
once the decision to provide particular treat­
ment(s) has been made. Conversely, if the 
episode of care is the unit of analysis, the 
entire set of interrelated services involved in 
the delivery of medical care to treat a specific 
problem over time can be captured, as well 
as the results achieved through the delivery of 
those services. Therefore, focusing on episodes 
of care allows for a more direct assessment of 
the linkage between the provision of specific 
services (and their costs) and the outcomes of 
those services. 
Third, it was believed that episodes can 
foster and enable new strategies for financing 
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healthcare that may eliminate current incentives 
to overuse certain services (e.g., imaging for 
low back pain) and underuse others (e.g., 
preventive care such as colon cancer screening). 
An episode approach can also facilitate the 
development of alternate payment models that 
compensate processes of care that have been 
shown to contribute to better patient outcomes 
(e.g., patient self-management support and 
medication reconciliation),20,21 as well as 
equitably reward all healthcare professionals 
who deliver care across the episode. 
Finally, at least in theory, an episode 
approach based on prolonged episodes (one 
year or more) can provide more generalizable 
insights into the overall performance of 
delivery systems. Patients with diabetes, heart 
attacks, cancer, depression, or other serious 
chronic conditions will tend to experience other 
acute or chronic conditions during their period 
of follow-up. Whether the outcomes and cost 
of care over time for different conditions are 
highly correlated will thus be an important 
empirical question. If overall performance on 
one condition predicts longitudinal performance 
on another, then a measurement framework 
that focuses on important, high-prevalence 
“tracer” conditions might be generalized to 
provide meaningful comparisons across 
delivery systems, communities, and regions. 
Limitations of an Episode of Care Approach 
Despite the advantages enumerated above, the 
Committee recognized the limitations associated 
with evaluating efficiency across episodes. 
These stem mainly from challenges entailed in: 
1) addressing appropriateness of care; 2) risk-
adjusting for different populations; 3) sorting 
out patients with multiple chronic conditions; 
and 4) facilitating comparisons among 
organizations. 
Determining the appropriateness of care is 
critical from two standpoints. First, it is important 
to ensure that patients receive evidence-based 
interventions for which they are eligible (even 
if they cost more). For example, screening for 
breast or colorectal cancer may incur some 
early costs, but the potential benefits from early 
intervention with regard to patient outcomes 
and cost savings are often not realized until 
years downstream. Conversely, it would be 
wrong to label a provider as “efficient” for 
performing a procedure at low cost and with 
a good outcome if the procedure should not 
have been performed in the first place—either 
because it was not clinically indicated or, if 
clinically indicated, the patient would not have 
chosen to receive it (based on personal values) 
if fully informed of the risks and benefits. An 
example of the latter would include many 
instances of surgery for low back pain. 
A recent analysis by the Medicare Advisory 
Payment Commission (MedPAC) of two 
episode grouper tools provides an example of 
the challenges inherent in measuring efficiency 
with current commercial measures. MedPAC 
found that Miami, Florida, appeared to be 
more efficient than Minneapolis, Minnesota, in 
terms of relative resource use per episode for 
coronary artery disease (CAD).22 However, 
upon further investigation it was discovered 
that Medicare beneficiaries in Miami were 
diagnosed and treated much more frequently 
for CAD and other heart-related episodes than 
those in Minneapolis. Thus, Miami’s CAD 
expenditures alone were spread across more 
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episodes, giving the appearance of lower 
costs and greater provider efficiency but 
masking the possibility of overdiagnosis and 
overtreatment. 
An important lesson from the examples 
above is that episode groupers do not neces­
sarily distinguish the appropriateness of clinical 
services and patient preferences for the clinical 
services rendered, and therefore efficiency 
measurement based purely on episodes must 
be balanced with population-based, per capita 
resource use measures.23 Other options would 
be to measure the number of episodes per 
capita of a given type of service or to measure 
the degree to which care is aligned with well-
informed patients’ preferences. 
Two other limitations also deserve mention. 
One is that episodes of care traditionally have 
been constructed on a condition-by-condition 
basis. This is not a patient-centric approach, 
because the majority of patients cope with 
more than one chronic condition. Therefore, 
capturing quality and cost of care for patients 
that account for multiple comorbidities and 
thus overlapping episodes is a methodological 
challenge that still needs to be resolved in 
order to create a patient-centric measurement 
framework. Another limitation is that the 
episode of care strategy does not facilitate 
comparisons of relative efficiencies of one 
organization versus another—efficiencies that 
may indeed transcend diseases. This limitation 
emphasizes the need for at least some institution-
specific or site-specific measurement to support 
quality improvement and patient choice. 
The limitations of an episode of care 
approach clearly point to the need for a 
comprehensive measurement system that not 
only can accurately and reliably assess the 
efficiency of care delivered but also can 
monitor for appropriateness of care; account 
for patient preferences; address diverse 
populations and those with multiple chronic 
conditions; and allow for meaningful compar­
isons across organizations to support quality 
improvement and patient values. Indeed, one 
of the major obstacles to adopting an episode 
of care model is the translation of theory into 
practice—as the Committee recommends the 
ability to measure outcomes not only in the 
short term (e.g., 30-day mortality) but also 
over extended intervals (e.g., initially at one 
year, and then three to five years and beyond), 
which has yet to be successfully mastered on 
a wide scale basis. 
The following discussion presents the 
Committee’s conceptualization of an episode 
of care model that can be applied broadly to 
acute and chronic conditions. This generic 
episode follows a patient through the experience 
of care, followed by discussion of the specific 
domains of measurement proposed by the 
Committee. 
Generic Episode of Care 
Figure 1 illustrates a generic model for tracking 
a patient with a health problem and for 
measuring and evaluating the core components, 
or phases, of the episode of care. This model 
is adaptable to multiple types of episodes, and 
it provides a foundation for working out case 
scenarios. It incorporates the measurement 
domains—patient-level outcomes, cost and 
resource use, and processes of care—that are 
essential for evaluating the efficiency of care, 
while recognizing that judgments of value 
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Figure 1: Generic Episode of Care 
Population at Risk 
PHASE 1 
Clinical episode begins 
End of Episode 
• Risk-adjusted health outcomes 
(i.e., mortality & functional status) 
• Risk-adjusted total cost of care 
PHASE 2 
PHASE 3 
Evaluation & Initial 
Management Follow-up Care 
Appropriate Times Throughout Episode 
• Determination of key patient attributes for 
risk-adjustment 
• Assessment of informed patient preferences 
and the degree of alignment of care 
processes with these preferences 
• Assessment of symptom, functional, and 
emotional status 
Time 
require an understanding of patient prefer-
ences—thus highlighting the importance of 
actively engaging patients in their healthcare 
decisions. Appendices D and E discuss the 
application of this model to two common 
conditions, acute myocardial infarction (AMI) 
and low back pain, respectively. 
Because a growing body of evidence 
alerts us to the potentially harmful, unintended 
consequences of measurement approaches that 
focus too narrowly on guideline adherence for 
individuals with multiple chronic conditions,24,25 
this model should be viewed as the first stage 
of an evolutionary strategy that will be informed 
by emerging evidence. The complexity of illness, 
the clustering of illnesses (e.g., a diabetic 
patient with heart disease, back pain, and 
depression), and other health risks (e.g., risk 
for falls, delirium, or pressure ulcers) will 
require over time a more sophisticated model 
that allows for the measurement of how well 
clinical services are aligned with patient 
needs, preferences, and social supports. 
The generic model for evaluating the 
efficiency of care over time consists of three 
phases: 1) population at risk, 2) evaluation 
and initial management, and 3) follow-up 
care. These three phases are considered 
foundational to any assessment of efficiency 
regardless of the type of health problem 
presented—acute, chronic, or a combination 
thereof. 
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Phase 1: Population at Risk 
The Committee acknowledged that primary 
prevention of a health problem, both in a 
generic sense for this model and more specifi­
cally for an acute condition with long-term 
chronic implications such as heart attack, is 
the most efficient approach to care—from the 
patient’s perspective and with respect to societal 
resources. Thus, the Committee believed that 
a strategy for evaluating health promotion 
and primary prevention may require sampling 
from a population of patients other than those 
who have started in the clinical phase of the 
episode of care. 
Phase 2: Evaluation and Initial Management 
This phase begins at the onset of clinical illness, 
and it should include an initial assessment of 
an informed patient’s preferences with regard 
to the available treatment options and, if 
warranted, palliative care. An assessment of 
the key, evidence-based processes of care and 
a determination of how well the processes align 
with the patient’s preferences should occur at 
appropriate times during this phase. For some 
more complex episodes, it may be informative 
to ascertain relevant measures such as quality 
of life, functional status, morbidity/ mortality, 
patient experiences with care, and costs. 
Phase 3: Follow-Up Care 
Measurement during this phase should focus 
on seamless care coordination, targeting 
care transitions and medication reconciliation, 
particularly during hand-offs between providers 
and across different settings. Initiation of 
appropriate secondary prevention also figures 
prominently in this phase. Patient preferences 
should continue to inform which processes 
of care are executed. Ongoing evaluation of 
relevant patient outcomes may be appropriate. 
Assessment at the End of the Episode of Care 
At the end of the episode of care—the length 
of which will vary depending on the type of 
health problem—two key outcomes should 
be assessed: 1) patient-level outcomes and 
2) overall resource use. Patient-level outcomes 
ideally should include risk-adjusted morbidity 
and mortality and domains that encompass 
health-related quality-of-life measures such as 
patient self-reported functional status. Resource 
use comprises the risk-adjusted total cost of 
care across the entire episode. Risk adjustment 
should use a well-tested and validated statistical 
model to account for the key patient demo­
graphic and clinical factors that affect out­
comes. The Committee recommended that for 
chronic conditions the initial standard should 
be to evaluate patient-level outcomes and total 
cost of care at one year, and, when feasible, 
at three to five years or beyond. 
Domains 
The following domains represent the essential 
components and subcomponents for measuring 
efficiency as it relates to an episode of care. 
All of these domains are important, because 
there is a need for a complement of measures 
that will pull providers together across the full 
trajectory of a particular episode, which will 
vary. A focus on longitudinal efficiency implies 
overall assessment of both quality and cost. 
Clear insights will require measuring the key 
components needed by stakeholders so they 
can judge quality, cost, and value. 
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In selecting the domains, the Committee 
strove for balance—hoping to ensure that they 
were comprehensive enough to accurately and 
fairly evaluate performance both at the system 
and provider level without imposing an undue 
burden for data collection. In keeping with the 
original statement of purpose, it was also critical 
that the domains capture patient-level outcomes 
and that they be capable of detecting waste in 
the system or of exposing unjustifiable costs. 
Therefore, the Committee recommended three 
overarching domains—patient-level outcomes, 
cost and resource use, and processes of 
care—for assessing efficiency, and ultimately 
value, across healthcare episodes. 
Domain 1: Patient-Level Outcomes 
Drawing on the earlier work of Donabedian, 
the Committee recognized the utility of 
understanding measurement in terms of the 
classical structure-process-outcome triad.26 The 
Committee also acknowledged that the current 
repertoire of performance measures consists 
predominately of process measures (e.g., 
administration of aspirin after AMI); far fewer 
structural measures (e.g., nurse staffing levels); 
and only a sprinkling of outcome measures 
(e.g., 30-day mortality for AMI). Nonetheless, 
the Committee advocated for collecting and 
reporting patient-level outcome measures, and 
it viewed doing so as an essential component 
of any efficiency assessment—whether at the 
overall healthcare system level or at the indi­
vidual provider level. Hence, there is an urgent 
need for additional outcome measures to be 
developed, tested, and more fully implemented. 
In the meantime, the selection of existing 
process/structure measures for purposes of 
accountability and quality improvement should 
be guided by an evidence base that sufficiently 
links the measures to desirable patient outcomes 
and that results in as parsimonious a set of 
measures as possible to ensure adequate 
breadth and high compliance. 
Health Status/Health-Related Quality of Life 
In addition to evaluating outcomes such 
as morbidity and mortality for a particular 
condition or treatment intervention, other 
important constructs to be measured in this 
domain include patient self-perception of 
health status, functional status, and physical 
and psychological health. These variables 
represent key dimensions of health-related 
quality of life (HRQoL), which is a more rele­
vant and appropriate construct for chronically 
ill populations because of its focus on the 
aspects of an individual’s overall well-being 
that are affected by progressive changes in 
health status and the quality of healthcare. 
The ability to cope with functional deficits 
and views about the meaning of one’s life is 
prominent among the factors that can signifi­
cantly affect an individual’s perceptions of 
health status and quality of life. These percep­
tions also can be influenced by the quality of 
healthcare services.27,28,29 HRQoL is consistent 
with the current emphasis on “person-centered 
care” (healthcare responsive to the person’s 
wants, needs, and preferences), a principle 
stressed in recent IOM reports on quality.30 
Data on the multiple domains of HRQoL can 
inform decisions about the use of innovative 
clinical practices or technologies for this popu­
lation. Recent studies have demonstrated the 
significance of HRQoL measures in selecting 
among alternative interventions and in guiding 
decisionmaking when there is a real tradeoff 
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between length and quality of life.31 Many 
standardized survey instruments have been 
developed to measure these dimensions of 
outcome.32 
Patient Experience with Care 
Patient experience with care over an episode-
based encounter is an equally important out­
come for determining the overall efficiency of 
care delivery. Therefore, feedback should be 
solicited from patients and their families in a 
formal and systematic fashion and then acted 
upon. One such mechanism for doing so is 
the administration of a survey tool such as the 
CAHPS® family of instruments.33 
Domain 2: Cost and Resource Use 
The most important measure of resource use 
would be one that captures the total cost of 
care across the episode—both the quantity of 
services provided to patients and the true costs 
paid for each service. Because prices paid for 
identical services can vary across geographic 
areas and among payers, and because indi­
vidual providers may not have control over all 
prices, measures of overall resource use based 
on both the actual prices paid and standard­
ized prices are important. Other measures that 
can help provide insight into differences in 
resource use include the volume of services, 
such as the quantity of physician visits and 
the number of hospital or nursing home days 
provided to patients during the episode. 
Another measure of resource whose usefulness 
is supported by a growing evidence base are 
nursing intensity weights, which are relative 
values that reflect the quantity and types of 
nursing services provided to patients in each 
diagnosis-related group.34 It is also important 
to consider opportunity costs to patients result­
ing from inefficiencies in the healthcare system 
(e.g., time wasted waiting for an appointment) 
as well as out-of-pocket costs for care. 
Domain 3: Processes of Care 
This domain includes measures of process, 
such as administration of an evidence-based 
bundle of appropriate medications at admission 
and discharge for patients who have had a 
heart attack. To minimize the data collection 
burden, process measures should be strongly 
linked to desired intermediate and final 
outcomes. 
Also within this domain is the important 
process of engaging patients proactively in 
shared decisionmaking. This collaborative 
process between patients and their providers 
is specifically designed to assist them in 
making informed choices—aligned with their 
preferences and values—regarding potential 
treatment options. Measuring decision quality 
becomes particularly relevant in determining 
the appropriateness of care, as discussed 
earlier, because many patients when given 
balanced information will choose not to have 
a given procedure or diagnostic test, even if 
they meet eligibility and appropriateness 
requirements.35 
Guiding Principles 
The following principles are intended to guide 
the development and implementation of the 
Committee’s recommended measurement 
framework as applied across episodes of care. 
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Principle 1: Efficiency measurement is 
multidimensional. 
Judgments about efficiency should be based 
on a comprehensive set of measures that 
adequately portray performance in three 
domains: patient-level outcomes, cost and 
resource use, and processes of care. Explicitly, 
these domains should drive toward outcomes 
relevant to all the IOM aims for the healthcare 
system in addition to efficiency including 
safety, timeliness, effectiveness, equity, and 
patient-centeredness. Therefore, efficiency 
measurement is by definition multidimensional 
and as such should be evaluated accordingly. 
Principle 2: The choice of measures to 
inform judgments on efficiency should 
include consideration of potential 
leverage. 
When choosing among potential measures, 
consideration should be given to those that 
have the highest likelihood of positively 
influencing desirable patient outcomes at 
reasonable costs and that offer the greatest 
opportunity to spur system-level improvement. 
Process measures should have strong evidence 
of their link to outcomes. 
Principle 3: Measures used to inform 
judgments on efficiency should 
promote shared accountability across 
providers and should be assigned to 
the smallest unit of accountability as 
technically feasible. 
To promote shared accountability for patient 
outcomes and total costs across episodes, the 
framework for efficiency measurement should 
address all levels within the healthcare system, 
including individual patients, independent 
healthcare professionals, provider organiza­
tions, and communities. When feasible, and 
when data can support measures that are 
valid, accurate, and reliable, the smallest unit 
of accountability should be measured and 
reported. 
Principle 4: Measures used to inform 
judgments on efficiency should 
respond to the need to harmonize 
measurement across settings of care. 
For existing measures, efforts should be made 
to reconcile measurement specifications/ 
definitions among healthcare professionals 
(e.g., physicians, nurses) and across multiple 
settings (e.g., ambulatory, hospital, nursing 
home, home health, community, populations). 
The development of new measures should 
strive for harmonization and should include 
measures that cross settings of care. 
Principle 5: Measures to inform 
judgments on efficiency should be 
used for benchmarking. 
When assessing efficiency of care either at 
the individual healthcare professional, provider 
organization, or system level, performance 
should be compared to, or indexed against, an 
appropriate benchmark. Whenever possible, 
benchmarks should reflect the current assessment 
of best attainable care (based on both quality 
and cost)—not simply average performance— 
and should be tracked over time. 
Principle 6: Public reporting of 
measures of efficiency should be 
meaningful and understandable to 
consumers and entities accountable 
for their care. 
Publicly reported data on efficiency—quality 
and cost of care—should be meaningful and 
useful to consumers, accountable care entities 
being measured, and other relevant stakehold­
ers. Data should be presented in a format that 
is understandable to consumers and other 
end users so they can easily make informed 
judgments about both providers and treatments. 
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Principle 7: Inappropriate care cannot 
be efficient. 
Measures to inform judgments on efficiency 
should be capable of detecting misuse, overuse, 
and underuse of care within the episode time-
frame. Inappropriate care, including failing to 
provide an evidence-based intervention to an 
eligible patient or administering an intervention 
that is unwarranted, cannot be efficient. 
Principle 8: The measurement 
framework should achieve its intended 
purpose and should be monitored for 
unintended consequences. 
A measurement framework that is designed to 
inform judgments on efficiency should facilitate 
improving health and reducing the cost and 
burden of illness. As such, the framework 
should be periodically (every three to five 
years) evaluated to ensure its effectiveness, 
and it should be continuously monitored to 
safeguard against unintended consequences. 
Principle 9: Measures to inform 
judgments on efficiency should be an 
integral part of a continuous learning 
system. 
In addition to assessing individual healthcare 
professionals, provider organizations, and sys­
tem performance, efficiency measurement also 
should be designed for continuous learning to 
inform clinical practice, measure development, 
policy, and the research agenda. 
Path Toward a 
Comprehensive 
Measurement System 
Many stakeholder groups have spent a con­
siderable amount of time identifying the best 
available measures, and they have engaged in 
substantial and well-intentioned efforts to collect 
the data needed to populate the databases for 
these measures and to generate public reports 
on clinical aspects of the quality of care and, 
in some instances, patient perspectives on care. 
Until recently, with the exception of a handful 
of innovators in the field, too few attempts 
have been made to define and measure 
efficiency in ways that combine measures 
of resource use with measures of other impor­
tant dimensions of quality including safety, 
timeliness, effectiveness, equity, and patient­
centeredness. The work of this Committee is 
meant to help advance the field by highlighting 
the need for a measurement framework that 
recognizes the longitudinal nature of health-
care (i.e., episodes of care) and places 
emphasis on both quality and cost. 
The Committee recognized that there are 
many hurdles to measuring efficiency across 
extended episodes of care. First, a more 
comprehensive measurement system needs to 
evolve—one that is capable of assessing the 
clinical efficiency of care as well as monitoring 
for unintended consequences, supporting 
continuous quality improvement, adequately 
adjusting for risk, and determining the appro­
priateness of care. However, the lack of such 
an ideal system should not prevent us from 
moving forward. Rather, the framework can 
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serve as a blueprint for what we are trying 
to achieve. The Committee recognized that 
achieving the goal of a comprehensive 
measurement system will require adopting a 
phased approach to implementation. 
Second, the Committee recognized that 
many technical issues will need to be resolved 
including: 
❙ how to ensure data integrity; 
❙ how data should be aggregated and at 
what level (i.e., national versus local); 
❙ how best to adjust for varying case/severity 
mix among different providers; 
❙ how to attribute care across multiple 
providers; and 
❙ how to develop new measures to fill gaps 
in the episode of care framework. 
Third, the Committee realized that changing 
performance measurement to a patient-focused, 
episode of care approach, as described, will 
be difficult, particularly because current 
accountability and payment systems tend to 
focus on individual providers and distinct 
settings of care. 
Although a full discussion of these issues is 
beyond the scope of this report, the Committee 
discussed these and other challenges, and it 
also held a workshop to solicit input on these 
issues from additional content experts in the 
field. Based on these discussions, the 
Committee agreed that the path toward imple­
mentation will require efforts to integrate and 
coordinate local providers and their data, and 
it will necessitate the development of practical 
approaches to support the collaborative and 
integrative work required to improve care 
across episodes that span multiple providers 
and diverse settings of care. To achieve these 
goals an organizational context for the work 
must be established. The Committee believed 
that this is likely to require the fostering of 
shared accountability through the development 
of “accountable care entities” to provide (or 
effectively manage) the continuum of care as a 
real or virtually integrated local delivery system. 
The Committee recommended that such an 
organizational structure have the following 
characteristics: 
❙ organizational commitment to patient-
centered focus for measurement including 
routinely collecting and acting upon patient 
and family caregiver feedback; 
❙ strong organizational structure with a locus 
of accountability with clear authority, and a 
receptive environment with financial incen­
tives, collaboration, and communication 
within and across providers and settings 
of care; 
❙ information management systems that 
include seamless information exchange 
across providers and settings; and 
❙ learning systems with a quality improvement 
infrastructure that can engage providers 
and drive improvement with mechanisms for 
innovation and learning within and across 
organizations. 
This organizational structure could take 
many forms. For example, it could be an 
existing integrated delivery system such as 
the Geisinger Health System, described in 
Appendix A. Other alternative structures 
might include multispecialty group practices, 
physician-hospital organizations/practice 
networks, regional collaboratives, or health 
plans serving as the locus of accountability 
for a network of providers, or conceivably an 
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“advanced medical home” with a designated 
health professional playing a coordinating role 
for his or her patients.36 All of these potential 
structures have strengths and weaknesses and 
undoubtedly would face formidable barriers in 
current markets, but the Committee believed 
that some level of organizational accountability 
will almost certainly be required and that 
learning which organizational forms are 
most successful (in what contexts) will require 
both pilot testing and careful evaluation of 
alternative approaches. 
In closing, the measurement framework 
presented here is viewed as a living document 
that will continue to evolve as we learn more 
about how to adapt this model to individuals 
with complex chronic illnesses, including frail 
elders, and to population-based approaches. 
The Committee recognized that there are many 
other determinants of health that necessitate 
better integration between the public health 
and personal health systems, as well as com­
pounding issues around access and disparities, 
that warrant further work on fully incorporating 
these areas into a farther-reaching performance 
measurement system. Nonetheless, this frame­
work provides a starting point for identifying 
measurement gaps and for examining models 
of shared accountability to help move us closer 
to attaining a high-performing, high-value 
healthcare system. 
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Case Studies
 
The 100,000 Lives Campaign 
THE 100,000 LIVES CAMPAIGN—spearheaded by the Institute for Healthcare 
Improvement—engaged more than 3,000 hospitals in an 18-month project during which 
an estimated 122,000 deaths were avoided by improving the quality and efficiency of 
care. Healthcare organizations were encouraged to implement up to six interventions 
including 1) deploying rapid response teams in inpatient settings at the first sign of patient 
decline; 2) delivering a core, evidence-based bundle of clinical services to patients who 
experienced a heart attack; 3) reconciling medications throughout care to avert adverse 
drug events; 4) preventing central line infections; 5) preventing surgical site infections; and 
6) preventing ventilator-associated pneumonia (VAP).37 
Virginia Mason Medical Center (VMMC) employs tenets derived from Toyota’s “Lean 
Production System,” which maps out processes of care in step-by-step detail to look for 
opportunities to eliminate waste. VMMC chose the reduction of the incidence of VAP and its 
related complications from the 1000,000 Lives Campaign interventions as one target, and 
it implemented “VAP care bundles,” which consisted of four relatively simple interventions, 
such as elevating the head of the bed. As a result of these actions, VAP decreased from 
40 patients per year in 2000 to 5 per year in 2006, with an estimated savings to the 
institution of $1.7 million.38 
Geisinger Health System 
THE GEISINGER HEALTH SYSTEM (GHS) in central Pennsylvania has a pilot program 
named ProvenCare that offers a “90-day guarantee” on the heart bypass surgeries that 
its physicians perform.39 The program consists of 40 steps that are designed to ensure 
that best practices are followed during both pre- and post-operative care and to eliminate 
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variation across physicians and facilities. 
Since the inception of the program in February 
2006, preliminary findings suggest that 
patients have spent fewer days in the hospital, 
have been less likely to be readmitted for 
surgery-related complications, and have 
returned to their homes after discharge as 
opposed to making an intermediary stop at 
a nursing home. To avoid the pitfalls of the 
current fee-for-service financing system that 
rewards more procedures and trips back to the 
hospital, GHS’s network of hospitals charge 
insurers a flat fee for the surgery and half the 
amount of the cost of care related to the surgery 
three months after discharge based on historical 
data. No charges are incurred for follow-up 
treatment beyond this amount. Thus, the incen­
tive exists to administer high-quality care as 
efficiently as possible to avoid preventable 
readmissions and to stay within the capitated 
allowance. 
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Appendix C 
Application of Key Terms and Definitions: Case Scenario 
THE FOLLOWING PRESENTS an exercise in which the concepts of cost and quality as 
measures of efficiency can allow for judgments of the value of care delivered to patients. 
Table 1 shows that the “average cost of care per diabetic episode” for Physician 1 is 
$1,500. What this means, quite simply, is that the average reimbursable expense (for 
services billed to an insurer) for diabetes care delivered to Physician 1’s panel of patients 
over some time interval was $1,500. One might argue that this amount does not truly 
capture the total cost of care for those diabetics, but that argument is about the validity of 
the measure and not about the underlying construct. So, for the moment, let us proceed. 
Table 1 
PHYSICIAN AVERAGE COST PER DIABETIC EPISODE 
1 $1,500 
Table 2 shows that the cost of diabetes care for Physician 2 is $1,250—significantly less 
than that for Physician 1. It would be accurate and meaningful to state that Physician 2 pro­
vides diabetes care (on average) at a lower cost than does Physician 1. But the inferences 
one can make from that statement are limited; it is a matter of fact, but it provides insufficient 
basis for a decision about which physician is more efficient. 
Table 2 
PHYSICIAN 
1 
AVERAGE COST PER 
DIABETIC EPISODE 
$1,500 
NOTES 
2 $1,250 Physician 2 provides diabetes care at a lower 
cost than Physician 1. 
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Table 3 provides critical additional information about the quality of care that Physicians 1 and 2 
provide. They have very different rates of success with respect to achieving an outcome (HgbA1c 
target) relevant to (that is, an indicator for) a health benefit. It is accurate to suggest that Physician 
1 provides higher quality diabetes care40 than does Physician 2 (just as it was accurate to suggest 
that Physician 2 provides lower cost care). 
Table 3 
PHYSICIAN 
1 
AVERAGE COST PER 
DIABETIC EPISODE 
$1,500 
PERCENTAGE OF PATIENTS 
AT HgbA1c TARGET 
80 
NOTES 
2 $1,250 60 Physician 1 provides higher 
quality diabetes care than 
Physician 2. 
Does that mean that Physician 1 is more efficient? Using the definition of efficiency adopted by 
the Committee, the answer must be “we don’t know.” Physicians 1 and 2 do not achieve the same 
outcome (so we cannot use their relative costs to make an inference about efficiency), and they do 
not achieve the different outcomes at the same cost (so we cannot use their relative outcomes to 
judge efficiency). 
Fortunately, we meet Physician 3 in Table 4. Physician 3 achieves the same outcome as 
Physician 1 but at a lower cost. Physician 3 provides care at the same cost as Physician 2 but 
achieves a better outcome. So Physician 3 is clearly more efficient than Physicians 1 and 2. While 
we can make no comment about Physicians 1 and 2, we have the data that we need to make an 
important observation that is relevant to our understanding of the performance of all physicians in 
the set. 
What if Physician 3’s outcome was better than Physician 1’s (e.g., 90 percent) or was achieved 
at a lower cost than Physician 2’s (e.g., $1,000 per episode)? It is no longer strictly true that 
Physician 3 achieves a better outcome than Physician 1 at the same cost (or achieves the same 
outcome as Physician 2 at a lower cost). Are we unable to comment on efficiency because there is 
no strict equality? 
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Table 4
 
PHYSICIAN 
1 
AVERAGE COST PER 
DIABETIC EPISODE 
$1,500 
PERCENTAGE OF PATIENTS 
AT HgbA1c TARGET 
80 
NOTES 
2 $1,250 60 
3 $1,250 80 Physician 3 is more “efficient” 
than Physician 1. (Physician 3 
provides same quality at lower 
cost) and Physician 3 is more 
efficient than Physician 2 
(Physician 3 provides higher 
quality at same cost). 
Of course not. If one physician achieves a better outcome at a lower cost than another, that 
physician is clearly more efficient. This is the strategy behind most current efforts to assess efficien­
cy—to array physicians on cost and quality axes and to look for those in the “northwest corner” 
(that is, those whose quality is above average and whose cost is below average). 
Table 5 provides important additional information about Physicians 1, 2, and 3. We are reminded 
by the data in Table 5 that quality is multidimensional, that is, that consumers value the quality of 
their experience as well as the physiologic outcome associated with clinical encounters. 
Table 5 
AVERAGE COST PER PERCENTAGE OF PATIENTS PERCENTAGE OF PATIENTS “VERY 
PHYSICIAN DIABETIC EPISODE AT HgbA1c TARGET SATISFIED” WITH COMMUNICATIONS 
1 $1,500 80 90 
2 $1,250 60 90 
3 $1,250 80 60 
Table 5 shows that Physicians 1, 2, and 3 achieve different outcomes with respect to their 
patients’ assessments of the quality of their communication skills. Inferences about efficiency are no 
longer quite so clear. On the other hand, it may be possible to make some statements about value. 
Which physician offers care that represents the highest value? The Committee’s answer: “That 
depends.” In particular, it depends on the rate at which the potential receiver of services trades off 
cost for one or the other outcome (clinical/physiologic or experiential) or the rate at which the 
receiver trades off those outcomes themselves. 
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These, in turn, depend on individual prefer­
ences. The high-income patient—or the patient 
with deep insurance—who is committed to the 
control of his diabetes may gladly trade off the 
additional cost he faces for the better outcome 
that Physician 1 achieves. To that patient, this 
cost-quality combination represents high value. 
Not so, perhaps, to the patient who is less 
concerned about his diabetes and/or who can 
less afford the cost differential. And not so, 
perhaps, to the employer, who may face the 
prospect of cutting back on the benefits her 
company can offer if that company has to 
face the costs that attend Physician 1’s care. 
From this employer’s perspective, Physician 3 
may represent the highest value—acceptable 
clinical outcomes at a lower cost. Or it may 
be Physician 2, if that employer believes that 
a level of satisfaction of 60 percent would be 
seen as unacceptable (or at least perceived 
very negatively) by employees and their 
families. 
The point simply is this: The value each 
physician/each cost-quality combination 
represents depends on the preferences of the 
individual/stakeholder making the valuation. 
Different people in different settings (and 
conceivably at different times in their lives) will 
value these combinations differently. Efficiency 
is objective; when measured as the Committee 
suggested, all observers would agree on 
rank order. The inputs of cost and quality to 
value are objective, but the determination itself 
is not. 
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Appendix D 
Context for Considering an AMI Episode 
THE COMMITTEE’S CURRENT EFFORTS to define episodes of care and to establish a 
performance measurement framework must be understood in the context of a relatively sim­
ple goal: to improve health and reduce the burden of illness while maximizing the value of 
individual and societal resources allocated to healthcare. This goal implies a responsibility 
to consider the definition of an episode within a broader context. In the case of acute 
myocardial infarction (AMI), for example, a responsible evaluation of a healthcare delivery 
system should consider the efficiency with which each patient with an AMI received care 
and the frequency with which AMI occurred in the community. Decisions about investments 
intended to improve health and reduce the burden of illness should take into account not 
only improved clinical services but also strategies that could effectively prevent the acute 
condition. 
The Committee’s proposed conceptual framework and episode model for AMI (Figure D-1), 
however, is constrained by the realities of the current capabilities of performance measure­
ment systems and our capacity to implement episode-based measurement systems. Therefore 
the Committee decided to focus primarily on the relatively discreet definition of an AMI 
episode that begins with the onset of chest pain and continues through the period that may 
be required for recovery and stabilization—recognizing the importance of the period pre­
ceding the AMI. As such, the Committee defined four distinct phases of the care of patients 
with AMI that purposively correspond with the Foundation for Accountability’s (FACCT)41 
domains of consumer needs: the population at risk, acute care, post-acute care/rehabilitation, 
and secondary prevention. Thus, the Committee focused on the latter three phases of the 
episode, because these represent the most direct, concrete, and easily measured components 
of AMI care. The population at risk is included in the episode model, because it remains 
important to look “upstream” to understand and perhaps intervene to prevent AMI. 
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Figure D-1: Context for Considering an AMI Episode 
Population at Risk 
1o Prevention 
(no known CAD) 
2o Prevention 
(CAD no prior AMI) 
2o Prevention 
(CAD with prior AMI) 
Advanced Care Planning 
Acute 
Phase 
Post Acute/ 
Rehabilitation 
Phase 
2o Prevention 
PHASE 1 
PHASE 2 PHASE 3 PHASE 4 
Staying Healthy Getting Better Living w/ Illness/Disability (T1) 
Coping w/ End of Life (T2) 
Episode begins — 
onset of symptoms 
Episode ends — 
1 year post AMI 
Post AMI Trajectory 1 (T1) 
Relatively healthy adult 
Focus on: 
• Quality of Life 
• Functional Status 
• 2o Prevention Strategies 
• Rehabilitation 
• Advanced Care Planning 
Post AMI Trajectory 2 (T2) 
Adult with multiple co-morbidities 
Focus on: 
• Quality of Life 
• Functional Status 
• 2o Prevention Strategies 
• Advanced Care Planning 
• Advanced Directives 
• Palliative Care/Symptom Control 
Assessment of 
Preferences 
The Committee first recognized that individu­
als with AMI tend to follow one of two trajecto­
ries that have different outcomes and different 
ideal patterns of care—an acknowledged 
simplification but one that is useful for both 
measurement and conceptual clarity. 
Individuals in Trajectory 1 (T1) are relatively 
healthy at the time of their initial MI and, if 
care is effectively delivered, they should expect 
to return to active, productive lives following 
recovery from the MI. Those in Trajectory 2 
(T2) have their MI superimposed on serious 
underlying illness (i.e., multiple chronic condi­
tions). For these patients, AMI represents an 
additional (and perhaps final) assault in their 
progression toward increased frailty and 
death. In either case, however, the Committee 
believed it important to identify distinct phases 
of care and most importantly to assess and 
adhere to patients’ preferences. 
Episode Phases 
Phase 1: Population at Risk 
Ideally, in evaluating the performance of a 
healthcare system in addressing the problems 
of AMI, it would be important to consider the 
population at risk of AMI and to capture the 
period preceding the event, when it is conceiv­
able that the first heart attack could have been 
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prevented—either through appropriate primary 
prevention that occurs in populations with no 
prior evidence of heart disease or through 
secondary prevention for those with known 
coronary artery disease (CAD). 
Phase 2: Acute Phase 
The acute MI phase should begin with the 
onset of symptoms (although this will be difficult 
to measure in most current approaches) and 
end at 30 days postindex hospital discharge. 
The advantage of focusing on symptom onset 
lies in the opportunity it affords to address sys­
tem-level interventions including the adequacy 
of the emergency medical response system and 
access to cardiac revascularization facilities 
in a community. Optimally, at the point of 
entry, patients should be assessed as to which 
trajectory—T1 or T2—they fall into (although 
at times this distinction may not be clear) so 
that appropriate treatment protocols can be 
followed. For patients who clearly enter under 
T2, it is imperative that their advance care 
plan be adhered to and that their preferences 
be respected. Regardless of trajectory, this 
phase should capture the acute care provided 
to the patient from arrival at the emergency 
department, through appropriate diagnosis, 
treatment, and stabilization. This would include 
any initial revascularization and the appropriate 
management of complications, and would 
extend through the transition to rehabilitation 
and post-AMI management. 
Phase 3: Post-acute care/ 
Rehabilitation Phase 
The Committee proposed that rehabilitation 
(Phase 3) be the focus of the episode of care 
from the end of the acute phase (Phase 2) 
through three months post-index hospital 
discharge (while acknowledging that post-
acute care begins the day of admission and 
may continue for an extended period). In T1, 
where the patient is relatively healthy at the 
time of AMI, the focus should be on gaining 
medical stability and returning to work and 
normal activities of daily living. Additionally, 
advance care planning should be initiated. 
In T2, the focus also should be on achieving 
medical stability through symptom control and 
returning to pre-MI activities of daily living. 
Advance care planning, if not already in 
place, should be implemented. For patients 
who are coping with end of life, the emphasis 
should be on sustaining the highest quality of 
life possible along with palliative care that is 
respectful of the patients’ and their family’s 
preferences. 
Phase 4: Secondary Prevention 
The Committee recommended that secondary 
prevention (Phase 4) be the focus of the 
episode of care from the end of rehabilitation 
(Phase 3) through one-year postindex hospital 
discharge (once again acknowledging that 
this phase begins at hospital admission and 
continues through rehabilitation), as this cohort 
of patients is at higher risk of reoccurrence of 
a heart attack. Key interventions include lipid 
management, control of high blood pressure, 
and appropriate medication, along with 
counseling with regard to smoking cessation, 
diet, and physical activity. 
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Appendix E 
Context for Considering a Low Back Pain Episode 
FOR “PREFERENCE SENSITIVE DECISIONS” such as spine care, treatment decisions 
are almost always made around pain and function. This is in contrast to “effective care 
decisions” relevant to, for example, acute myocardial infarction (heart attack), which is 
a specific diagnosis with well-defined diagnostic and treatment strategies. Therefore, an 
episode for low back pain must be conceptualized differently, which has implications for 
measuring the efficiency (quality and cost) of care as well as for reimbursement. 
Figure E-1: Context for Considering a Low Back Pain Episode
 
Confirm back pain syndrome; Rule out red 
flags (i.e. malignancy, infection) 
Population at Risk 
Evaluation & Shared Decision Surgery or Follow-up 
Initial Making & Medical Care & 
Management Informed Choice Treatment Prevention 
Adults with back pain 
PHASE 3 PHASE 4 PHASE 5 
PHASE 2 
PHASE 1 
Patient baseline assessment of function, 
mental health & comorbidities 
Getting Better	 Staying Healthy (T1) 
Living w/ 
Illness/Disability (T2) 
Episode begins — Episode ends — 
onset of symptoms 1 year 
Trajectory 1 (T1) 
Returning back to work & 
ies assuming normal activit
of daily living
Focus on: 
• Quality of Life 
• Functional Status 
• als Patient-Generated Go
• Education and
Prevention of Future 
Episodes
Trajectory 1 (T1) 
Patient at risk for long-
term chronic disability 
Focus on: 
• Quality of Life
• Functional Status
• als Patient-Generated Go
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Episode Phases 
Phase 1: Population at Risk 
The population at risk for this phase is charac­
terized by adults with low back pain. 
We begin by defining low back pain as 
“mechanical low back or leg pain” to designate 
an anatomical or functional abnormality without 
an underlying malignant, neoplastic, or inflam­
matory disease—representing 97 percent of 
42,43cases.
Phase 2: Diagnosis and Initial 
Management 
In the context of this episode of care, low 
back pain begins with the onset of symptoms. 
Providing an exact anatomical diagnosis for 
low back pain is often challenging as the 
majority of patients cannot be neatly catego­
rized. Therefore, this ambiguity heightens the 
importance of a detailed but focused medical 
history and physical exam that can 1) rule out 
“red flags” such as malignancy, infection, 
trauma, or cauda equine; 2) establish the 
presence of comorbidities (e.g., depression) 
that can influence patient outcomes;44 
3) determine a prior history of back pain 
also indicative of future outcomes; and 
4) assess neurological manifestations that 
may necessitate additional diagnostic studies 
or a surgical option.45 
Additionally, an essential piece of information 
to collect during this phase is a self-assessment 
of the patient’s health status (e.g., SF36 or 
SF12). This should be done not only to inform 
the provider during initial evaluation and 
management but also to obtain baseline data 
on the patient’s physical functioning, degree 
of pain, and mental health status, from which 
outcomes during the follow-up phase of this 
episode (Phase 5) can be benchmarked and 
overall judgments with regard to the efficiency 
of treatment interventions can be made. 
Often the information gathered above is 
sufficient to formulate a treatment plan without 
the need for diagnostic imaging. The overuse 
of diagnostic imaging may induce demand 
for unnecessary interventions (e.g., surgery, 
injections, and further diagnostic testing 
such as discography, x-rays) from incidental 
abnormalities detected on the scan, which can 
potentially lead to higher morbidity and costs 
downstream.46 Once “mechanical low back 
pain” is confirmed, we can continue to Phase 3. 
Phase 3: Shared Decisionmaking 
and Informed Choice 
During this phase, patients are offered a 
variety of decision support aids (e.g., written 
materials, videos, web-based programs, 
one-on-one consultations) that lay out evidence-
based treatment options, including risks and 
benefits, for their condition. Options include, 
for example, surgery or medical treatment 
(e.g., physical therapy, medications) for low 
back pain. Patients then engage in discussions 
with their healthcare providers to make 
informed choices about which treatment path 
they wish to take based on their preferences 
and values. Thus, key elements of an informed 
choice process include using tools that objec­
tively inform patients of their alternatives— 
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while elucidating their preferences and val­
ues—and incorporating both the patients’ and 
providers’ perspectives in the decisionmaking 
process.47 
Phase 4: Surgery or Medical 
Treatment 
During this phase, the patient’s favored treat­
ment for this preference sensitive decision is 
initiated in accordance with evidence-based 
or consensus-based protocols. The patient’s 
expectations of the treatment outcomes should 
ideally be consistent with the evidence base 
(or best available knowledge) that was shared 
with the patient during the structured informed 
choice process that took place in Phase 3. 
Phase 5: Follow-Up Care and 
Prevention 
During this phase, patients are evaluated at 
three to six months post-treatment, including 
reassessment of their health status, which is 
compared against their baseline score 
obtained in Phase 2. Feedback pertaining to 
overall satisfaction/experience with care is 
also captured. 
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